Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
暂无分享,去创建一个
H. Khamis | A. Reda | A. Bendary | A. Elbahry | E. Farag | T. Mostafa | O. Sanad | A. Elserafy | N. Farag | A. Elkersh | M. Selim | M. Beshay | Mohammed Selim